In the Doctor of Pharmacy (Pharm.D.) program, we will equip you with the knowledge and experiences you need to thrive as a pharmacist in a variety of settings or to succeed in a post graduate training or degree program. In short, we'll prepare you to advance the practice and profession of pharmacy.
For six of the past eight years, our graduates have passed the North American Pharmacist Licensure Examination (NAPLEX) on their first attempt at rates that exceed national averages; in 2013, 97.5% of our graduates passed the exam on their first attempt. The Multistate Pharmacy Jurisprudence Examination (MPJE) pass rate for McWhorter School of Pharmacy graduates has been higher than the national average since 2005; our graduates passed at a rate of 97.6% in 2013.
The graduation rate of all students admitted to the McWhorter School of Pharmacy since the fall of 2001 (Class of 2005 through Class of 2013) is greater than 97%. Since 2001, more than 95% of our admitted students have graduated in four years.
Admission to the McWhorter School of Pharmacy is based on merit. McWhorter School of Pharmacy participates in the Early Decision program through PharmCAS. For complete details on the application process, check out the admission requirements below.
Admission to the McWhorter School of Pharmacy is competitive, meaning all applications are considered on merit. To process our applications, we use the PharmCAS system. To be considered for admission to the Doctor of Pharmacy program, you must have:
Please note: It is your responsibility to follow up with the McWhorter School of Pharmacy Office of Admission on items needed to complete your file.
Early Decision through PharmCAS
The McWhorter School of Pharmacy now offers Early Decision (ED) status through PharmCAS. The Early Decision program is a binding option for applicants who have decided that a particular pharmacy degree program is their first choice and that they will enroll if accepted. Learn more about Early Decision.
A 1978 graduate of the McWhorter School of Pharmacy, Randy Nelson has managed some of the world's leading pharmaceutical companies.